Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quaker Chemical (KWR) Operating Leases (2019 - 2025)

Quaker Chemical (KWR) has disclosed Operating Leases for 7 consecutive years, with $22.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Operating Leases rose 13.64% to $22.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $22.8 million, a 13.64% increase, with the full-year FY2025 number at $22.8 million, up 13.64% from a year prior.
  • Operating Leases was $22.8 million for Q4 2025 at Quaker Chemical, down from $35.1 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $39.0 million in Q4 2022 to a low of $20.0 million in Q4 2024.
  • A 5-year average of $29.5 million and a median of $27.4 million in 2022 define the central range for Operating Leases.
  • Peak YoY movement for Operating Leases: crashed 41.17% in 2023, then skyrocketed 43.46% in 2024.
  • Quaker Chemical's Operating Leases stood at $36.3 million in 2021, then increased by 7.38% to $39.0 million in 2022, then crashed by 41.17% to $22.9 million in 2023, then fell by 12.68% to $20.0 million in 2024, then grew by 13.64% to $22.8 million in 2025.
  • Per Business Quant, the three most recent readings for KWR's Operating Leases are $22.8 million (Q4 2025), $35.1 million (Q3 2025), and $24.3 million (Q2 2025).